Abstract
Background: Wearable smartwatches enable objective quantification of physical activity. This study evaluated the association of extravalvular cardiac damage in aortic stenosis with smartwatch‐recorded physical activity before and after transcatheter aortic valve implantation (TAVI). Methods: Patients with severe symptomatic aortic stenosis were dichotomized into cardiac damage stages 0 to 2 (left‐heart dysfunction) and stages 3 to 4 (pulmonary/right‐heart dysfunction) by echocardiography. All patients received a Fitbit smartwatch for 7 days of continuous monitoring before transcatheter aortic valve implantation and at 6‐month follow‐up. Regression models determined significant predictors of total daily step count and moderate to vigorous physical activity (MVPA). Results: Within the study cohort (stages 0–2: 43 [50.6%]; stages 3–4: 42 [49.4%]), all patients showed significant improvement in physical activity from baseline to follow‐up (all P P P =0.002; MVPA: β=−12.9 [95% CI, −24.3 to −1.5], P =0.027) and follow‐up (step count: β=−1438.1 [95% CI, −2453.9 to −422.3], P =0.006; MVPA: β=−27.4 [95% CI, −47.7 to −7.1], P =0.009), as well as less improvement in MVPA (β=−14.5 [95% CI, −28.4 to −0.48], P =0.043) after transcatheter aortic valve implantation. Conclusions: The extent of cardiac damage before transcatheter aortic valve implantation has an important impact on physical activity, both at baseline and following intervention. Future studies should examine whether smartwatch‐measured activity predicts death across cardiac damage stages and whether cardiac rehabilitation improves outcomes in aortic stenosis with advanced remodeling.

This publication has 50 references indexed in Scilit: